Adaptimmune
Develops therapies to treat cancer. Learn more
Launch date
Employees
Market cap
€258m
Enterprise valuation
€106m (Public information from Sep 2024)
Share price
$1.01 ADAP
Company register number 06456741
Milton England (HQ)
Authorizing premium user...